# EDGAR Filing Document

**Accession Number:** 0000091576
**File Stem:** 0000091576-23-000034
**Filing Date:** 2023-2
**Character Count:** 9434
**Document Hash:** cfd025d36a08450033006a2470149210
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000091576-23-000034.hdr.sgml**: 20230222

**ACCESSION NUMBER**: 0000091576-23-000034

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230217

**FILED AS OF DATE**: 20230222

**DATE AS OF CHANGE**: 20230222

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Kidik Allyson M
- **CENTRAL INDEX KEY:** 0001937969

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11302
- **FILM NUMBER:** 23653669

**MAIL ADDRESS:**
- **STREET 1:** 127 PUBLIC SQUARE
- **CITY:** CLEVELAND
- **STATE:** OH
- **ZIP:** 44114
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KEYCORP /NEW/
- **CENTRAL INDEX KEY:** 0000091576
- **STANDARD INDUSTRIAL CLASSIFICATION:** NATIONAL COMMERCIAL BANKS [6021]
- **IRS NUMBER:** 346542451
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 127 PUBLIC SQ
- **CITY:** CLEVELAND
- **STATE:** OH
- **ZIP:** 44114-1306
- **BUSINESS PHONE:** 2166896300

**MAIL ADDRESS:**
- **STREET 1:** 127 PUBLIC SQ
- **CITY:** CLEVELAND
- **STATE:** OH
- **ZIP:** 44114-1306

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SOCIETY CORP
- **DATE OF NAME CHANGE:** 19920703

## Ex-24

```
<pre>
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549

    RE:    Commission File No. 0-805
        1933 Act and 1934 Act Filings
        Authorized Representatives

Gentlemen:

    KeyCorp ("Company") is the issuer of securities registered under Section 12 of the Securities Exchange Act of 1934.  The undersigned confirms that James L. Waters, Andrea R. McCarthy, Richard A. Kopek and Adam J. Larkins and each of them ("Authorized Representatives"), are authorized on his or her behalf to sign such statements (on Form 3, Form 4, Form 5, or otherwise) with respect to securities of the Company (the "Securities"), and to submit to the Securities and Exchange Commission such filings (including reports, notices, and other statements) with respect to the Securities, as are required by the Securities Act of 1933 or the Securities Exchange Act of 1934 (collectively, the "Acts").  The undersigned also confirms the authority of each of the Authorized Representatives to do and perform, on his or her behalf, any and all acts and things with respect to the Securities requisite or necessary to assure compliance by the signing person with the filing requirements of the Acts.  The authority confirmed herein shall remain in effect as to the undersigned until such time as the Commission shall receive a written communication terminating or modifying the authority.

/s/ Allyson M. Kidik                        January 26, 2023
Signature                            Date

Allyson M. Kidik
(Type or Print Name)

</pre>
```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Kidik Allyson M<br><sub>(Last) (First) (Middle)</sub><br>127 PUBLIC SQUARE<br><sub>(Street)</sub><br>CLEVELAND, OH 44114<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-17 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Risk Review Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>KEYCORP /NEW/ [ KEY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Shares | 2023-02-17 |  | M |  | 2221 | A | <sup>(1)</sup> | 16960 | D |  |
| Common Shares | 2023-02-17 |  | F |  | 794 | D | $19.15 | 16166 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | 2023-02-17 |  | M |  |  | 659 | <sup>(2)</sup> | <sup>(2)</sup> | Common Shares | 659.0<sup>(3)</sup> | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2023-02-17 |  | M |  |  | 563 | <sup>(4)</sup> | <sup>(4)</sup> | Common Shares | 563.0 | $0 | 563<sup>(5)</sup> | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2023-02-17 |  | M |  |  | 595 | <sup>(6)</sup> | <sup>(6)</sup> | Common Shares | 595.0 | $0 | 1187<sup>(7)</sup> | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2023-02-17 |  | M |  |  | 405 | <sup>(8)</sup> | <sup>(8)</sup> | Common Shares | 405.0 | $0 | 1213<sup>(9)</sup> | D |  |
| Restricted Stock Units | <sup>(1)</sup> | 2023-02-17 |  | A |  | 3916 |  | <sup>(10)</sup> | <sup>(10)</sup> | Common Shares | 3916.0 | $0 | 3916 | D |  |
| Option to Buy | $21.07 | 2023-02-17 |  | A |  | 5910 |  | <sup>(11)</sup> | 2033-02-17 | Common Shares | 5910.0 | $0 | 5910 | D |  |

---

### Footnotes:

(1) Each restricted stock unit represents the right to receive one KeyCorp common share at vesting.

(2) These restricted stock units, granted on February 18, 2019, vested in four equal annual installments ending on February 17, 2023.

(3) Includes approximately 15 dividend-equivalent restricted stock units accrued between September and December 2022.

(4) These restricted stock units, granted on February 17, 2020, vest in four equal annual installments beginning on February 17, 2021.

(5) Includes approximately 25 dividend-equivalent restricted stock units accrued between September and December 2022.

(6) These restricted stock units, granted on February 15, 2021, vest in four equal annual installments beginning on February 17, 2022.

(7) Includes approximately 40 dividend-equivalent restricted stock units accrued between September and December 2022.

(8) These restricted stock units, granted on February 14, 2022, vest in four equal annual installments beginning on February 17, 2023.

(9) Includes approximately 37 dividend-equivalent restricted stock units accrued between September and December 2022.

(10) The restricted stock units, granted on February 17, 2023, vest in four equal annual installments beginning on February 17, 2024.

(11) The option to buy, granted on February 17, 2023, vests in four equal annual installments beginning on February 17, 2024.

**Signature:** Adam J. Larkins POA for Allyson M. Kidik  
**Date:** 2023-02-22

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**